CELG-RI NYSE
Bristol-Myers Squibb Company Ce
1W: +18.1%
1M: -12.7%
3M: +29.2%
YTD: +62.2%
1Y: +289.2%
3Y: -7.7%
$0.13
+0.02 (+17.45%)
Weekly Expected Move ±23.1%
$0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$263.9M
52W Range0.023-0.2749
Volume5,485
Avg Volume16,036
Beta-0.47
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOChristopher S. Boerner
Employees34,100
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2019-11-21
Websitebms.com
Route 206 & Province Line Road
Princeton, NJ 8543
US
Princeton, NJ 8543
US
+1 609 252 4000
About Bristol-Myers Squibb Company Ce
Bristol Myers Squibb Company (BMS) operates as a biopharmaceutical enterprise, managing the entire lifecycle of its therapeutic products, from initial discovery and development to manufacturing, marketing, and distribution. Its diverse portfolio includes conventional small molecule drugs, advanced biologics (which are derived from biological processes), and specialized chimeric antigen receptor (CAR-T) cell therapies. The company was established in August 1933 and maintains its corporate headquarters in Princeton, New Jersey.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Poole Ahn Amanda | 0 | — | 2024-01-01 | |
| Poole Ahn Amanda | 4,822 | — | 2024-01-01 | |
| Poole Ahn Amanda | 3,214 | — | 2024-01-01 | |
| YALE PHYLLIS R | A-Award | 658 | — | 2023-12-31 |
| Storch Gerald L | A-Award | 706 | — | 2023-12-31 |